Sotera Health Q1 FY26 net income turns to profit; net revenues rise 10% to 280.05 million
PUBT · 1d ago
Share
Listen to the news
- Sotera Health Q1 net revenues rose 10% to $280.05 million.
- Net income swung to $27 million, or $0.09 per diluted share.
- Adjusted EBITDA increased 10.5% to $134.65 million, lifting adjusted EBITDA margin 0.2 percentage points to 48.1%.
- Sterigenics net revenues climbed 9.7% to $186.14 million, while Nordion net revenues jumped 29% to $42.01 million.
- Full-year 2026 outlook reaffirmed for constant-currency net revenues growth of 5%–6.5% and adjusted EBITDA growth of 5.5%–7%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605050703PRIMZONEFULLFEED9713224) on May 05, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved